𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Over-expression of the epidermal growth factor receptor in human breast cancer cells fails to induce an Estrogen-independent phenotype

✍ Scribed by Eva M. Valverius; Thierry Velu; Vidya Shankar; Fortunato Ciardiello; Nancy Kim; David S. Salomon


Publisher
John Wiley and Sons
Year
1990
Tongue
French
Weight
993 KB
Volume
46
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


An association exists in primary human breast tumors between high epidermal growth factor receptor (EGFR) expression and a reduced number or even absence of estrogen receptors (ER). To determine whether an increase in EGFR expression might alter the estrogen responsiveness of an ERpositive human breast cancer cell line, ZR 75-1 cells were cotransfected with a plasmid containing the full-length cDNA for the human EGFR under the transcriptional control of the Harvey murine sarcoma virus (HaMSV) long terminal repeat (LTR) and with a pSV2neo plasmid. Two of the isolated G4 18resistant clones were found to constitutively express EGFR levels 15to 60-fold higher than those found on nontransfected ZR 75-I cells. The EGFR in these clones were functionally normal since EGF could increase their autophosphorylation and since EGF could enhance the transphosphorylation of p185erbe-2. No change was seen in either the number or affinity of ER in these clones. In addition, the ability of estrogen to stimulate the anchorage-dependent and anchorageindependent growth of these clones was not significantly modified. These results suggest that an increase in EGFR expression alone is not sufficient to induce a hormoneindependent phenotype in vitro in human breast cancer cells.


📜 SIMILAR VOLUMES


Inhibition of proliferation and inductio
✍ Manuela Campiglio; Alberta Locatelli; Clelia Olgiati; Nicola Normanno; Giulia So 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 2 views

High expression of the epidermal growth factor receptor (EGFR) in breast carcinoma confers a growth advantage to the tumor cells. The EGFR tyrosine kinase inhibitor (EGFR-TKI) ZD1839 ('Iressa') has clinical activity in a wide range of tumor types, although the mechanism(s) by which it exerts its ant

Downregulation of the antiapoptotic MCL-
✍ Yvonne Andersson; Siri Juell; Øystein Fodstad 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 582 KB

## Abstract __Pseudomonas__ exotoxin (PE)–containing immunotoxins (ITs) act by arresting protein synthesis and promoting apoptosis, but the mechanisms of the induced apoptosis and the relationship to protein synthesis inhibition is not well elucidated. We studied these effects in MA‐11 human breast